Respiratory

show blocks helper

Sort by Default

Display 15 Products per page

Market Spotlight: Idiopathic pulmonary fibrosis (IPF)

$1,318.00

This Market Spotlight report covers the Idiopathic pulmonary fibrosis (IPF) market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
July 31, 2020
Find out more
Disease Analysis: Asthma – Forecast and Market Analysis to 2027
Read More
Asthma is a chronic respiratory condition characterized by recurrent wheezing, coughing, and breathlessness, which occur in acute events known as exacerbations. Often triggered by factors such as exercise, allergen or irritant exposure, change in weather, or viral respiratory infections, these flare-ups can vary significantly in frequency and severity. Attacks consist of swelling of the lining of the bronchial tubes, which narrows airways and results in a reduction of airflow into and out of the lungs. Historically considered to be a single disease, asthma is now viewed more as an overlapping assemblage of individual phenotypes with various underlying pathophysiological processes leading to symptoms.
April 1, 2020
Find out more
Drug Delivery: Inhalation Devices

$4,750.00

This comprehensive market and medical technology report provides an overview of the inhalation-based devices used in the management of asthma and chronic obstructive pulmonary disease (COPD), and includes an in-depth, product-specific market analysis. Countries covered by this report comprise the US, the five major EU markets (France, Germany, Italy, Spain, and the UK), and Japan.
October 7, 2019
Find out more
Chronic Obstructive Pulmonary Disease Forecast and Market Analysis to 2026
Read More
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. In 2004, it was the fourth most common cause of death in the world.
January 22, 2019
Find out more
Respiratory Care: Airway Management Accessories and Sleep Apnea Products

$4,750.00

The two most prevalent respiratory diseases, asthma and COPD, affect more than 480 million people worldwide. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for airway management accessories.
November 27, 2018
Find out more
Interventional Cardiology: Vascular Access Site Closure Products

$4,750.00

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries.
October 26, 2018
Find out more
Respiratory Care: Ventilators and Pulmonary Function Assessment Products

$4,750.00

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for ventilators (adult/ pediatric, neonatal, and transport) and pulmonary function assessment products (diagnostic spirometers and PFT devices) for the US, the five major EU markets, Japan, and the rest of world markets.
October 22, 2018
Find out more
Cystic Fibrosis Forecast and Market Analysis to 2025
Read More
Cystic fibrosis, caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) protein, is a rare and life-limiting genetic disorder that is characterized by thick, sticky mucus and pulmonary complications.
September 3, 2018
Find out more
Datamonitor Healthcare Respiratory: Idiopathic Pulmonary Fibrosis (IPF) Disease Coverage
Read More
Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease in which scarring and thickening of the lung tissue occurs due to unknown causes.
August 7, 2018
Find out more
Allergic Rhinitis Forecast and Market Analysis to 2034
Read More
Allergic rhinitis is a highly prevalent yet largely underdiagnosed chronic inflammatory disorder of the nasal mucosa, mediated by inappropriate inflammatory responses to environmental allergens including pollen and mold.
July 12, 2018
Find out more
Cystic Fibrosis Forecast and Market Analysis to 2025: Pipeline Report

$3,217.00

Cystic fibrosis, caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) protein, is a rare and life-limiting genetic disorder that is characterized by thick, sticky mucus and pulmonary complications.
September 4, 2017
Find out more
Cystic Fibrosis Forecast and Market Analysis to 2025: Marketed Drugs

$7,393.00

Cystic fibrosis, caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) protein, is a rare and life-limiting genetic disorder that is characterized by thick, sticky mucus and pulmonary complications.
September 4, 2017
Find out more
Cystic Fibrosis Forecast and Market Analysis to 2025: Epidemiology Report

$3,130.00

Cystic fibrosis, caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) protein, is a rare and life-limiting genetic disorder that is characterized by thick, sticky mucus and pulmonary complications.
September 4, 2017
Find out more
Cystic Fibrosis Forecast and Market Analysis to 2025: Treatment Report

$3,739.00

Cystic fibrosis, caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) protein, is a rare and life-limiting genetic disorder that is characterized by thick, sticky mucus and pulmonary complications.
September 4, 2017
Find out more
Cystic Fibrosis Forecast and Market Analysis to 2025: Forecast Report

$4,521.00

Cystic fibrosis, caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) protein, is a rare and life-limiting genetic disorder that is characterized by thick, sticky mucus and pulmonary complications.
September 4, 2017
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Call Back

Name

Email *

Company name *

Phone number *